Retatrutide appears to be a new treatment in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these https://nevemrsj239672.xzblogs.com/76811663/retatrutide-a-promising-new-treatment-for-obesity